Ziopharm Oncology Appoints Heidi Hagen to Board of Directors - NASDAQ Stock Market -BoardProspects

Ziopharm Oncology Appoints Heidi Hagen to Board of Directors

NASDAQ Stock Market Jun 17 2019 BoardMoves

BOSTON, June 17, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq:ZIOP), today announced Heidi Hagen, an experienced and entrepreneurial biotechnology operations executive, has been appointed to the Company's Board of Directors effective immediately...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- McKesson Shareholders Back Teamsters' Call For Independent Chairman - Quick Fact also published in NASDAQ Stock Market
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Wet Seal Elects Kathy Bronstein And John Goodman To Board - Quick Facts also published in NASDAQ Stock Market
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Sally Beauty Announces Board Retirements; Names Gary Winterhalter Chairman also published in NASDAQ Stock Market
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Topics Mentioned